Table 59Patient flow through trials–chlorpromazine versus ziprasidone

Intervention #1Intervention #2Intervention #3Intervention #4Intervention #5Intervention #6
Kane et al. 200696ClassificationFGASGA
MedicationChlorpromazineZiprasidone
Dosage100–1200mg/d40–160mg/d
No screened:NR
No randomized:489154152
No completed:135136
No analyzed (E):154152
No analyzed (S):154152

d = day; E = efficacy; FGA = first-generation antipsychotic; mg = milligram; No = number; NR = not reported; S = safety; SGA = second-generation antipsychotic

From: Appendix I, Patient Flow Through Trials

Cover of First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness
First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness [Internet].
Comparative Effectiveness Reviews, No. 63.
Abou-Setta AM, Mousavi SS, Spooner C, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.